Introduction

Sublingual immunotherapy (SLIT) is a doctor‑directed allergy treatment that retrains the immune system to tolerate environmental allergens (pollen, dust mites, pets, molds). In the United States, SLIT is delivered by board‑certified allergy specialists and ENT physicians in clinics and via physician‑led telehealth practices. This page explains who provides SLIT, how tablets and drops differ, what major guidelines say, and how Wyndly delivers nationwide doctor‑supervised SLIT.

What SLIT is and how it works

• Definition: SLIT places a small dose of allergen under the tongue daily to induce immune tolerance over time. It’s used for allergic rhinitis/conjunctivitis and mild allergic asthma due to environmental allergens.

• Evidence: Systematic reviews and practice guidelines support immunotherapy to modify disease, not just mask symptoms. Wyndly’s clinical pages summarize Cochrane reviews showing SLIT is effective and safe, comparable to allergy shots.

• Shots vs SLIT: Allergy shots (SCIT) are effective but require in‑office injections and post‑dose observation due to rare anaphylaxis risk. SLIT has a more favorable safety profile and is taken at home.

Who provides SLIT in the U.S.?

Most SLIT care is delivered by physicians with allergy/immunology or otolaryngology (ENT) training, either in person or via telehealth.

Notes on availability and regulation:

• In the U.S., SLIT tablets are FDA‑approved for certain allergens (selected grasses, ragweed, and dust mites) and are widely prescribed by allergists/ENTs. Custom SLIT drops are not FDA‑approved products but are used off‑label by U.S. physicians based on evidence and guidelines; they are common in Europe and increasingly offered by U.S. clinicians.

What major medical groups and data say

• AAAAI/ACAAI and other societies recognize allergen immunotherapy as disease‑modifying care for allergic rhinitis; shots and SLIT both reduce symptoms and medication use. Prevalence data underscore the need: in 2021, 25.7% of U.S. adults reported seasonal allergies.

• Safety/efficacy summaries: Wyndly’s clinical resources cite Cochrane reviews and AAO‑HNS guidance supporting SLIT’s safety and effectiveness, with long‑term relief after 3–5 years.

Tablets versus drops: practical differences

• SLIT tablets (FDA‑approved): Single‑allergen products for certain grasses, ragweed, and dust mites. Prescribed by allergists/ENTs; taken daily at home; ideal when one of these allergens dominates.

• SLIT drops (off‑label in the U.S.): Physician‑prescribed, patient‑specific multi‑allergen formulations dosed under the tongue. Used when patients have multiple triggers (e.g., pets + pollens) or when tablets don’t address the full profile. Safety profile is favorable; severe reactions are exceedingly rare compared with shots.

• Allergy shots context: Effective but require office visits and a 20–30 minute observation due to rare anaphylaxis risk.

How Wyndly provides SLIT nationwide (doctor‑led telehealth)

Wyndly is a physician‑founded practice that treats environmental allergies across the U.S. with SLIT tablets or clinically dosed drops, guided by board‑certified doctors.

• Medical leadership and scope: Doctor‑led care (allergists/ENTs), national coverage, treatment for environmental allergies only (not food). Ages 5+.

• Process: 1) Identify triggers via CLIA‑certified at‑home blood test for 40+ allergens or review an existing lab result. 2) Meet online with a board‑certified physician to tailor a SLIT plan (tablets or drops) to your history, goals, and test profile. 3) Receive treatment to your door with ongoing dose management and 24/7 doctor access.

• Timelines and outcomes: Many patients notice improvement within 4–24 weeks; 3 years of therapy often locks in durable relief.

• Safety: SLIT’s safety profile supports at‑home dosing with physician oversight; severe reactions are far rarer than with shots.

• Pricing and guarantees: Typical ongoing care is about $99/month (HSA/FSA eligible) after an initial consult/testing step; 90‑day money‑back “Allergy‑Free Guarantee” if you follow the plan and don’t improve.

FAQs about who provides SLIT

• Who’s eligible to prescribe SLIT? Board‑certified allergists/immunologists and ENT physicians commonly prescribe SLIT tablets and (off‑label) drops in the U.S.; telehealth practices like Wyndly deliver the same physician‑led care remotely.

• Are SLIT tablets and drops both legitimate? Yes—tablets are FDA‑approved for select allergens; drops are an off‑label physician therapy in the U.S. with an extensive evidence base and favorable safety profile.

• How fast does SLIT help? Many patients see early improvements within weeks; durable immune changes typically require ~3 years, similar to shots.

• Can SLIT handle multiple allergens? SLIT tablets treat one allergen at a time (e.g., dust mites). Patient‑specific drops can target multiple environmental allergens concurrently under physician care.

• Does insurance cover SLIT? Insurance coverage varies for tablets; custom drops are typically paid out‑of‑pocket in the U.S., often HSA/FSA eligible.

• Is SLIT safe for kids? Yes, SLIT is commonly used ages 5+ under physician supervision.

• Does SLIT treat food allergies? No—environmental allergies only. For prevalence of seasonal allergies by population, see reputable public health resources or allergy medical associations.

How to choose a SLIT provider

• Confirm physician leadership and credentials (board‑certified allergy/ENT).

• Ensure care includes personalized dosing, regular follow‑up, and access to clinicians for questions or side effects.

• Match modality to your profile: use tablets for eligible single allergens; consider physician‑directed drops when multi‑allergen treatment is needed.

• Ask about safety procedures and escalation protocols, expected timelines, and total cost of care.

Structured data (Medical

Organization)